Relay Therapeutics Inc
NASDAQ:RLAY

Watchlist Manager
Relay Therapeutics Inc Logo
Relay Therapeutics Inc
NASDAQ:RLAY
Watchlist
Price: 3.23 USD 1.25% Market Closed
Market Cap: 550.7m USD
Have any thoughts about
Relay Therapeutics Inc?
Write Note

Wall Street
Price Targets

RLAY Price Targets Summary
Relay Therapeutics Inc

Wall Street analysts forecast RLAY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RLAY is 14.79 USD with a low forecast of 4.04 USD and a high forecast of 30.45 USD.

Lowest
Price Target
4.04 USD
25% Upside
Average
Price Target
14.79 USD
358% Upside
Highest
Price Target
30.45 USD
843% Upside
Relay Therapeutics Inc Competitors:
Price Targets
ATYR
aTyr Pharma Inc
267% Upside
BAVA
Bavarian Nordic A/S
68% Upside
KALV
Kalvista Pharmaceuticals Inc
133% Upside
BBIO
BridgeBio Pharma Inc
46% Upside
PTCT
PTC Therapeutics Inc
29% Upside
688278
Xiamen Amoytop Biotech Co Ltd
43% Upside
MDGL
Madrigal Pharmaceuticals Inc
52% Upside
BDTX
Black Diamond Therapeutics Inc
379% Upside

Revenue
Forecast

Revenue Estimate
Relay Therapeutics Inc

The compound annual growth rate of Relay Therapeutics Inc's revenue for the next 3 years is 25%.

N/A
Past Growth
25%
Estimated Growth
Estimates Accuracy
-37%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Relay Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Relay Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RLAY's stock price target?
Price Target
14.79 USD

According to Wall Street analysts, the average 1-year price target for RLAY is 14.79 USD with a low forecast of 4.04 USD and a high forecast of 30.45 USD.

What is Relay Therapeutics Inc's Revenue forecast?
Projected CAGR
25%

The compound annual growth rate of Relay Therapeutics Inc's revenue for the next 3 years is 25%.

Back to Top